Himax Technologies (HIMX) has attracted fresh attention after issuing second quarter 2026 guidance that points to a 10% to 13% quarter over quarter net revenue increase, along with updated earnings and a new dividend declaration.

The guidance has landed against a backdrop of powerful momentum, with the share price at US$19.29 and a 30-day share price return of 73.78% alongside a 1-year total shareholder return of 137.62%. This signals strengthening sentiment despite earlier earnings pressure and a reduced dividend.

If this kind of sharp re-rating has your attention, it could be a good moment to look at other chip related opportunities and check out 43 AI infrastructure stocks

With Himax now at US$19.29 after a strong run, a fresh dividend declaration and guidance pointing to higher near term revenue, investors have to ask: is there still value on the table or is the stock already pricing in future growth?

Most Popular Narrative: 125.9% Overvalued

Compared with the most followed fair value estimate of $8.54, Himax at $19.29 sits well above that mark, and the widely tracked narrative leans heavily on long term product ramps to justify its stance.

The company's deepening engagement and design wins in emerging smart glasses/AR markets, underpinned by unique proprietary technologies in ultra-low power sensing (WiseEye), microdisplay, and nano-optics, create opportunities to capitalize on the rising demand for next-generation wearables, providing a new long-term revenue stream that will positively impact both top-line growth and margins.

It raises the question of what kind of revenue path and margin rebuild sit behind that fair value gap, and how long AR, WiseEye and CPO need to scale to support it.

Result: Fair Value of $8.54 (OVERVALUED)

However, this upbeat story still leans on assumptions that could be knocked off course by weaker demand across key segments or heavier pricing and margin pressure.

Next Steps

If this mix of excitement and concern feels familiar, now is the time to move quickly, review the data, and weigh both sides using the 1 key reward and 3 important warning signs.

Looking for more investment ideas?

If Himax has sharpened your focus, do not stop here. Fresh stock ideas can help you avoid concentration risk and spot opportunities you might otherwise miss.

• Seek potential mispricings by scanning companies that our models flag as promising in the 54 high quality undervalued stocks.
• Prioritize resilience by reviewing stocks highlighted for robust finances in the solid balance sheet and fundamentals stocks screener (46 results).
• Get ahead of the crowd by checking companies that stand out as compelling outliers in the screener containing 21 high quality undiscovered gems.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.